The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays
Open accessAbstract
Background—: Drug-induced arrhythmia is one of the most common causes of drug development failure and withdrawal from market. This study tested whether human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) combined with a low-impedance microelectrode array (MEA) system could improve on industry-standard preclinical cardiotoxicity screening methods, identify the effects of well-characterized drugs, and elucidate underlying risk factors for drug-induced arrhythmia. hiPSC-CMs may be advantageous over immortalized cell lines because they possess similar functional characteristics as primary human cardiomyocytes and can be generated in unlimited quantities. Methods and Results—: Pharmacological responses of beating embryoid bodies exposed to a comprehensive panel of drugs at 65 to 95 days postinduction were determined. Responses of hiPSC-CMs to drugs were qualitatively and quantitatively consistent with the reported drug effects in literature. Torsadogenic hERG blockers, such as sotalol and quinidine, produced statistically and physiologically significant effects, consistent with patch-clamp studies, on human embryonic stem cell–derived cardiomyocytes hESC-CMs. False-negative and false-positive hERG blockers were identified accurately. Consistent with published studies using animal models, early afterdepolarizations and ectopic beats were observed in 33% and 40% of embryoid bodies treated with sotalol and quinidine, respectively, compared with negligible early afterdepolarizations and ectopic beats in untreated controls. Conclusions—: We found that drug-induced arrhythmias can be recapitulated in hiPSC-CMs and documented with low impedance MEA. Our data indicate that the MEA/hiPSC-CM assay is a sensitive, robust, and efficient platform for testing drug effectiveness and for arrhythmia screening. This system may hold great potential for reducing drug development costs and may provide significant advantages over current industry standard assays that use immortalized cell lines or animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389
Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049
A structural basis for drug-induced long QT syndrome
Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210244497 · Cited by 944
AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS.
BAZETT, H. C. (1997) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.1997.tb00325.x · Cited by 808
He, J.-Q., Ma, Y., Lee, Y., Thomson, J. A., & Kamp, T. J. (2003) · Circulation Research · doi:10.1161/01.res.0000080317.92718.99 · Cited by 800
Ma, J., Guo, L., Fiene, S. J., Anson, B. D., Thomson, J. A., Kamp, T. J., Kolaja, K. L., Swanson, B. J., & January, C. T. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00694.2011 · Cited by 770
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696
Self-citationPatient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Carvajal-Vergara, X., Sevilla, A., D’Souza, S. L., Ang, Y.-S., Schaniel, C., Lee, D.-F., Yang, L., Kaplan, A. D., Adler, E. D., Rozov, R., et al. (2010) · Nature · doi:10.1038/nature09005 · Cited by 690
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., & Dolmetsch, R. E. (2011) · Nature · doi:10.1038/nature09855 · Cited by 677
Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current.
January, C. T., & Riddle, J. M. (1989) · Circulation Research · doi:10.1161/01.res.64.5.977 · Cited by 673
Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670
Self-citationLan, F., Lee, A. S., Liang, P., Sanchez-Freire, V., Nguyen, P. K., Wang, L., Han, L., Yen, M., Wang, Y., Sun, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.010 · Cited by 667
Self-citationLiang, P., Lan, F., Lee, A. S., Gong, T., Sanchez-Freire, V., Wang, Y., Diecke, S., Sallam, K., Knowles, J. W., Wang, P. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001883 · Cited by 537
Self-citationShimizu, W., & Antzelevitch, C. (1997) · Circulation · doi:10.1161/01.cir.96.6.2038 · Cited by 524
The impact of drug-induced QT interval prolongation on drug discovery and development
Fermini, B., & Fossa, A. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1108 · Cited by 492
Kannankeril, P., Roden, D. M., & Darbar, D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003723 · Cited by 440
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth, A., & Denning, C. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr073 · Cited by 389
Sartiani, L., Bettiol, E., Stillitano, F., Mugelli, A., Cerbai, E., & Jaconi, M. E. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0466 · Cited by 370
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., & Mummery, C. L. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.11.004 · Cited by 368
Kyrozis, A., & Reichling, D. B. (1995) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)00116-x · Cited by 343
Roden, D. M., & Hoffman, B. F. (1985) · Circulation Research · doi:10.1161/01.res.56.6.857 · Cited by 340
Cellular mechanisms underlying the long QT syndrome
Antzelevitch, C., & Shimizu, W. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200201000-00007 · Cited by 313
Assessing predictors of drug-induced torsade de pointes
Belardinelli, L., Antzelevitch, C., & Vos, M. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.002 · Cited by 302
Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes
Satin, J., Kehat, I., Caspi, O., Huber, I., Arbel, G., Itzhaki, I., Magyar, J., Schroder, E. A., Perlman, I., & Gepstein, L. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.068213 · Cited by 283
Guo, L., Abrams, R. M. C., Babiarz, J. E., Cohen, J. D., Kameoka, S., Sanders, M. J., Chiao, E., & Kolaja, K. L. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr158 · Cited by 272
Physicochemical Features of the hERG Channel Drug Binding Site
Fernandez, D., Ghanta, A., Kauffman, G. W., & Sanguinetti, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310683200 · Cited by 266
Genetics of acquired long QT syndrome
Roden, D. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25539 · Cited by 256
Generation of Endoderm-Derived Human Induced Pluripotent Stem Cells From Primary Hepatocytes
Liu, H., Ye, Z., Kim, Y., Sharkis, S., & Jang, Y.-Y. (2010) · Hepatology · doi:10.1002/hep.23626 · Cited by 250
Belles, B., Mal�cot, C. O., Hescheler, J., & Trautwein, W. (1988) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00587713 · Cited by 237
Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes
Cao, F., Wagner, R. A., Wilson, K. D., Xie, X., Fu, J.-D., Drukker, M., Lee, A., Li, R. A., Gambhir, S. S., Weissman, I. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003474 · Cited by 234
Self-citationDrug-induced long QT and torsade de pointes: recent advances
Kannankeril, P. J., & Roden, D. M. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32801129eb · Cited by 227
Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform
Ebert, A. D., Liang, P., & Wu, J. C. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318247f642 · Cited by 222
Self-citationIn Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes
Caspi, O., Itzhaki, I., Kehat, I., Gepstein, A., Arbel, G., Huber, I., Satin, J., & Gepstein, L. (2009) · Stem Cells and Development · doi:10.1089/scd.2007.0280 · Cited by 221
Induction and Isolation of Vascular Cells From Human Induced Pluripotent Stem Cells—Brief Report
Taura, D., Sone, M., Homma, K., Oyamada, N., Takahashi, K., Tamura, N., Yamanaka, S., & Nakao, K. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182162 · Cited by 200
Davidenko, J. M., Cohen, L., Goodrow, R., & Antzelevitch, C. (1989) · Circulation · doi:10.1161/01.cir.79.3.674 · Cited by 193
Beqqali, A., Kloots, J., Ward‐van Oostwaard, D., Mummery, C., & Passier, R. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0054 · Cited by 185
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes
Peng, S., Lacerda, A. E., Kirsch, G. E., Brown, A. M., & Bruening-Wright, A. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.01.014 · Cited by 183
Martin, R. L., McDermott, J. S., Salmen, H. J., Palmatier, J., Cox, B. F., & Gintant, G. A. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200403000-00007 · Cited by 178
Lee, P., Klos, M., Bollensdorff, C., Hou, L., Ewart, P., Kamp, T. J., Zhang, J., Bizy, A., Guerrero-Serna, G., Kohl, P., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.262535 · Cited by 173
Doss, M. X., Di Diego, J. M., Goodrow, R. J., Wu, Y., Cordeiro, J. M., Nesterenko, V. V., Barajas-Martínez, H., Hu, D., Urrutia, J., Desai, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040288 · Cited by 169
Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Lee, Y.-K., Ng, K., Lai, W., Chan, Y.-C., Lau, Y., Lian, Q., Tse, H., & Siu, C. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9273-3 · Cited by 163
Mordwinkin, N. M., Burridge, P. W., & Wu, J. C. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9423-2 · Cited by 131
Self-citationDavis, R. P., van den Berg, C. W., Casini, S., Braam, S. R., & Mummery, C. L. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.001 · Cited by 126
Abassi, Y. A., Xi, B., Li, N., Ouyang, W., Seiler, A., Watzele, M., Kettenhofen, R. F., Bohlen, H., Ehlich, A., Kolossov, E., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01623.x · Cited by 125
Organotypic slice culture from human adult ventricular myocardium
Brandenburger, M., Wenzel, J., Bogdan, R., Richardt, D., Nguemo, F., Reppel, M., Hescheler, J., Terlau, H., & Dendorfer, A. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr259 · Cited by 118
Otsuji, T. G., Minami, I., Kurose, Y., Yamauchi, K., Tada, M., & Nakatsuji, N. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.01.002 · Cited by 117
Jonsson, M. K. B., Wang, Q., & Becker, B. (2011) · Assay and Drug Development Technologies · doi:10.1089/adt.2011.0396 · Cited by 94
Alfuzosin Delays Cardiac Repolarization by a Novel Mechanism
Lacerda, A. E., Kuryshev, Y. A., Chen, Y., Renganathan, M., Eng, H. F., Danthi, S. J., Kramer, J., Yang, T., & Brown, A. M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128405 · Cited by 91
A mutation in HERG Associated with Notched T waves in Long QT Syndrome
Dausse, E., Berthet, M., Denjoy, I., André-Fouet, X., Cruaud, C., Bennaceur, M., Fauré, S., Coumel, P., Schwartz, K., & Guicheney, P. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0151 · Cited by 84
Mandenius, C., Steel, D. M., Noor, F., Meyer, T. S., Heinzle, E., Asp, J., Arain, S., Kraushaar, U., Bremer, S., Class, R., et al. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1663 · Cited by 77
El‐Sherif, N., Caref, E. B., Chinushi, M., & Restivo, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00700-1 · Cited by 74
Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
Narsinh, K., Narsinh, K. H., & Wu, J. C. (2011) · Circulation Research · doi:10.1161/circresaha.111.240374 · Cited by 71
Self-citationAbi‐Gerges, N., Ji, G. J., Lu, Z., Fischmeister, R., Hescheler, J., & Fleischmann, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-2-00377.x · Cited by 70
Patterson, S. D. (2005) · Drug Information Journal · doi:10.1177/009286150503900304 · Cited by 66
Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes
Jonsson, M. K. B., Duker, G., Tropp, C., Andersson, B., Sartipy, P., Vos, M. A., & van Veen, T. A. B. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.02.001 · Cited by 65
Cheng, H. C., & Incardona, J. (2009) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2009.05.010 · Cited by 33
Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity
Denning, C. N., & Anderson, D. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.08.002 · Cited by 33
Hao, L., Kameyama, A., & Kameyama, M. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.687ad.x · Cited by 33
Lack of Action Potential-Prolonging Effect of Terfenadine on Rabbit Myocardial Tissue Preparations
Masumiya, H., Saito, M., Ito, M., Matsuda, T., Noguchi, K., Iida‐Tanaka, N., Tanaka, H., & Shigenobu, K. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.131 · Cited by 25
Hao, L., Wang, W., Minobe, E., Han, D., Xu, J., Kameyama, A., & Kameyama, M. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09094fp · Cited by 18
Cited by
Screening out irrelevant cell-based models of disease
Horvath, P., Aulner, N., Bickle, M., Davies, A. M., Nery, E. D., Ebner, D., Montoya, M. C., Östling, P., Pietiäinen, V., Price, L. S., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.175 · Cited by 525
Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N., Mandegar, M., Conklin, B. R., Lee, L. P., et al. (2015) · Scientific Reports · doi:10.1038/srep08883 · Cited by 519
Karakikes, I., Ameen, M., Termglinchan, V., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.117.305365 · Cited by 478
Self-citationEvolution of strategies to improve preclinical cardiac safety testing
Gintant, G., Sager, P. T., & Stockbridge, N. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.34 · Cited by 407
Human Engineered Heart Tissue: Analysis of Contractile Force
Mannhardt, I., Breckwoldt, K., Letuffe-Brenière, D., Schaaf, S., Schulz, H., Neuber, C., Benzin, A., Werner, T., Eder, A., Schulze, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.011 · Cited by 398
Metadata
- Authors
- Navarrete, E. G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma, A., Burridge, P. W., Patlolla, B., Lee, A. S., Wu, H., Beygui, R. E., Wu, S. M., Robbins, R. C., Bers, D. M., & Wu, J. C.
- Venue
- Circulation
- Published
- 2013-09-10
- Volume
- 128
- Issue
- 11_suppl_1
- Pages
- S3-13
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2098952554
- Cited by
- 302
- References
- 65
- FWCI
- 23.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.